BIOCHEMICAL SOCIETY TRANSACTIONS teinase inhibitors was included in the lysing solution. To preclude the precipitation of non-specific material, lysates were pre-cleared twice with goat anti-( mouse IgG)agarose, followed by incubation with NB-1, an irrelevant antibody [4] .
Digestion of immunoprecipitated antigen for 4 h with trypsin at a final concentration of 1 mg/ml resulted in bands at 21 kDa, 16.5 kDa, 11.5 kDa, 10 kDa, 7.5 kDa and 5.8 kDa ( Fig. la; lane B) . Non-digested NC-2 immunoprecipitates incubated at 37°C for 4 h exhibited the usual banding pattern, demonstrating that fragmentation was indeed due to the addition of trypsin and not due to proteolysis by enzymes present within the lysate.
lmmunoprecipitated antigen was digested with 2.0 m-units of glycopeptidase F, an enzyme which hydrolyses all classes of asparagine-linked glycans, provided that both the aamino acid and carboxyl groups of the asparagine residues are present in a peptide linkage [S] . Digestion resulted in the usual bands and two additional bands, with molecular masses of 46 kDa and 38 kDa (Fig. 16) . The persistence of the 50 kDa band in glycopeptidase F-digested material may indicate that the reaction did not proceed to completion. However, repetition of the experiment using 5.0 m-units of the glycosidase resulted in a banding pattern identical to that obtained in the experiment in which 2.0 m-units of glycopeptidase F was used. Treatment of immunoprecipitated antigen with neuraminidase for 18 h did not visibly alter the mobility of the 50 kDa band in the gel, suggesting that the antigen is a glycoprotein without a large amount of sialic acid residues, while the glycopeptidase F digests indicate the presence of N-linked oligosaccharides.
We have examined the reactivity of the NC-2 antigen with cells from a variety of normal human tissues using the 'APAAP' immunocytochemical staining technique [6] . h epared slides were obtained commercially, each containing tissue sections from ovary, testis, thyroid, pancreas, lung, heart, kidney, liver, spleen, adrenal glands and gastrointestinal tract. Some degree of positive staining was observed in all except thyroid, pancreas, lung and spleen.
We have used immunofluorescence techniques to examine the internal location of the antigen and compare its distribution with that of a number of other well-characterized antigens expressed in HL-60 cells. Cells to be assayed for immunofluorescence were applied to microscope slides by cytocentrifugation, a process which flattens cells to some extent, enabling more internal detail to be distinguished than in unflattened cells. Antibodies directed against the X-hapten and a-tubulin respectively, produced staining patterns very distinct from that of NC-2. The pattern most similar to that of NC-2 was produced by the granulocytespecific antibody termed 82H 1, thought to be directed against carbohydrate sequences, some of which are present on the same 180 kDa protein as the X-hapten, although it has been shown not to be an anti-X antibody [7] . The pattern produced by NC-2 was granular, with distinct fluorescent spots visible internally. These fluorescent spots appear to be randomly distributed in the cytoplasm, suggesting a localization within granules. A similar pattern was observed by Baldari & Telford using a monoclonal antibody specific for a lysosomal antigen [8] .
The biochemical analysis and the subcellular localization studies of the NC-2-reacting antigen presented here provide the basis for future studies to discern the functional role of this glycoprotein.
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Introduction
Clofazimine (B663), a red iminophenazine dye [ 11, is very effective in the treatment of leprosy. Its mode of action is thought to be due to its inhibition of the template function of DNA. Resistance to the anti-leprosy agents rifampicin and dapsone has been widely reported and in 1982 a case of clofazimine-resistant leprosy was described [ 21. Hence, a number of analogues of clofazimine were synthesized in order to develop agents that might overcome such resistance [3-51. Studies on clofazimine and analogues were performed to determine which compounds had the required absorption characteristics in mice. The use of h.p.1.c. for the analysis of clofazimine and analogues was also investigated.
Materials and methoa's
Clofazimine and derivatives were synthesized as previously described [5] . The drugs were made up and thoroughly homogenized in 0.5% (w/v) carboxymethyl-cellulose and 0.5% (v/v) Tween 20. Animals (8-10-week-old Schofield mice) received a daily dosage of 20 mg day ' kg -I by gavage (0.4 ml) over a period of 3 weeks using a modified 5 cm human spinal needle. After 21 days the mice were killed. The lungs, liver, spleen and pelvic fat were removed and weighed. They were then placed in pre-weighed 5 ml Bijou bottles containing 0.5 ml of 25% (v/v) acetic acid. Organs were pooled, if appropriate. Serum samples were also taken. All samples were stored at -20°C. For drug extractions tissues were finely chopped, homogenized in 25% (v/v) acetic acid in a Elvehjem homogenizer and then carefully extracted ( x 4) with chloroform or other appropriate solvent, followed by 50% (v/v) phosphoric acid or hydrochloric acid [6] . Groups of three to six mice were used for each drug studied. The amount of drug extracted was then determined spectro-632nd MEETING, CORK 
Resirlts
The results obtained for the absorption of clofazimine and its analogues are shown in Table 1 . Since Mycobacteriurn leprae, the causative agent of leprosy, is an intracellular parasite, agents that concentrate in cells are generally suitable for therapeutic use against it. Clofazimine tends to concentrate in macrophages and this is a major factor in its effectiveness in leprosy treatment. It is also known to be an anti-inflammatory agent and this is probably related to its intra-macrophage location. However, clofazimine accumulates in fat and produces heavy skin discolouration, which is the major drawback associated with its use in humans.
The ideal analogue should have greater potency than clofazimine, produce less fat and skin discolouration and have a sustained therapeutic effect. Apart from B3954, no analogue produced very considerable fat or skin discolouration in this study. B3768 gave the highest levels in the spleen with B3962 over 100% lower. Both the spleen levels were significantly lower than that for clofazimine. The lowest levels in the spleen were recorded with 83889 and tests in vitro have also shown that it is much less effective than clofazimine against M. leprae.
However, even though B3962 showed much less uptake in the spleen, it was found to be more effective than clofazimine against M. leprae in vitro 141. Studies have shown that B3884 is much less active than B3954 or clofazimine against M . leprae [3] , but it gave higher splenic levels than B3954. Generally it has been found that compounds with the desired activity have a basic nitrogen in the side chain on the imino nitrogen, with the distance between this nitrogen and the imino nitrogen being three carbon atoms or greater [S].
These results clearly demonstrate the complex relationship between molecular structure and characteristics, absorption and anti-leprosy activity.
